Roche (RHHBY) said that it has expanded its collaboration with Janssen Biotech Inc. The New agreement expands activities to include a wide-range of companion diagnostics, including tissue and blood-based biomarkers, sequencing and digital pathology.
The collaboration builds on commitment to personalised healthcare through expanding access of companion diagnostics to enable targeted treatment options for patients, Roche said in a statement.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News